Application 074166
- Type
- ANDA
- Sponsor
- TEVA PARENTERAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOPOSAR | ETOPOSIDE | INJECTABLE;INJECTION | 20MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074166-001 | TOPOSAR | ETOPOSIDE | 20MG/ML | INJECTABLE / INJECTION | 1995-02-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A074166-001 | TOPOSAR | 20MG/ML | INJECTABLE / INJECTION | 1995-02-27 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074166-001 | TOPOSAR | 20MG/ML | INJECTABLE / INJECTION | 1995-02-27 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074166-001 | TOPOSAR | 20MG/ML | INJECTABLE / INJECTION | 1995-02-27 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Etoposide | ETOPOSIDE | Fresenius Kabi USA, LLC | fe870629-104d-4d67-a7c6-f53bc588121e | 2026-07-14 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | BluePoint Laboratories | 0dddbe44-b4f4-431f-9011-8a54abbd4cbf | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| VePesid | ETOPOSIDE | Amneal Pharmaceuticals NY LLC | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2026-05-15 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Meitheal Pharmaceuticals Inc. | 50491106-dddd-4efd-bd83-060e7947a244 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Accord Healthcare Inc. | 4f850eb2-3542-43a0-90e8-bb37fa05cf15 | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Hikma Pharmaceuticals USA Inc. | e0cd61b9-2375-4e3d-a610-d87dad962468 | 2024-09-05 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Hikma Pharmaceuticals USA Inc. | 6dfedeff-a807-4405-a482-2f7109ad31c9 | 2023-09-14 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | BluePoint Laboratories | 157d4e0f-806d-4011-9dec-97e2449e507b | 2018-06-20 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
| Etoposide | ETOPOSIDE | Mylan Pharmaceuticals Inc. | 508a418e-985f-4208-9324-2230655bb5c2 | 2016-04-19 | Boxed warning, Warnings, Adverse reactions | ETOPOSIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.